- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 3.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.98M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $10K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.32M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $7.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $307.65K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $284.88K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $307.65K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $284.88K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.06M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.4M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.44M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.81M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.38 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.83 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $888.64K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $888.4K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $541.66K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $743.3K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.41M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.64M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.46M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.66M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $0 |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.8K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.2K |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $3K |